1. Home
  2. AUB vs SYRE Comparison

AUB vs SYRE Comparison

Compare AUB & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlantic Union Bankshares Corporation

AUB

Atlantic Union Bankshares Corporation

HOLD

Current Price

$38.02

Market Cap

5.1B

Sector

Finance

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$69.47

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUB
SYRE
Founded
1902
2013
Country
United States
United States
Employees
3064
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
5.9B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
AUB
SYRE
Price
$38.02
$69.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
12
Target Price
$41.88
$85.08
AVG Volume (30 Days)
936.8K
1.3M
Earning Date
04-21-2026
05-08-2026
Dividend Yield
3.98%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$29.16
N/A
Revenue Next Year
$4.59
N/A
P/E Ratio
$19.68
N/A
Revenue Growth
N/A
N/A
52 Week Low
$28.11
$12.29
52 Week High
$42.18
$75.00

Technical Indicators

Market Signals
Indicator
AUB
SYRE
Relative Strength Index (RSI) 55.08 61.85
Support Level $34.59 $30.39
Resistance Level $39.26 $74.92
Average True Range (ATR) 0.88 4.51
MACD -0.05 -0.38
Stochastic Oscillator 42.93 59.54

Price Performance

Historical Comparison
AUB
SYRE

About AUB Atlantic Union Bankshares Corporation

Atlantic Union Bankshares Corp is a financial and bank holding company based in the U.S. Through its community bank subsidiary and non-bank financial services affiliates, the company provides financial services, including banking, trust, and wealth management. It offers consumers and businesses a wide range of banking and related financial services, including checking, savings, certificates of deposit, and other depository services, as well as loans for commercial, industrial, residential mortgage, and consumer purposes. The company operates through two reportable operating segments: Wholesale Banking and Consumer Banking, with corporate support functions such as corporate treasury and others included in Corporate Other. It derives maximum revenue from the Wholesale Banking segment.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: